Image

The Effect of Lullaby and Breastmilk Smell on Preterm Newborns

The Effect of Lullaby and Breastmilk Smell on Preterm Newborns

Non Recruiting
35-37 years
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to investigate the effect of live lullaby from mother voice, and breast milk smell on pyhsiological parameters, comfort and maternal attachment levels of preterm newborns who are between 35-37 weeks of gestation at the time of the study and the level of pospartum depression of mothers. The main hypothesis are:

H0: The live lullaby from mother voice and breast milk smell have no effects on pyhsiological parameters, comfort and maternal attachment levels of preterm newborns H1: The live lullaby from mother voice has effects on pyhsiological parameters, comfort and maternal attachment levels of preterm newborns H2: The breast milk smell has effects on pyhsiological parameters, comfort and maternal attachment levels of preterm newborns H3: There is differences between the live lullaby from mother voice and the breast milk smell interventions in terms of preterm newborns' physiological parameters, comfort and maternal attachment levels.

H4: The postpartum depression level of mothers in experimental groups (lullaby group and breast milk group) is lower than the control group.

Participants will be in three groups according to the interventions. The preterm newborns who are going to listen a live lullaby from their mothers' voice will be the first group (Lullaby group). The preterms in the second group (Breast milk group) are going to smell their mothers' breast milk. The preterms in the third group (Control group) are going to recieve rutin nursing care interventions.

Eligibility

Inclusion Criteria:

  • Parents' willingness to participate in the study
  • Turkish literate parents
  • Babies between 35-37 weeks of gestation
  • Apgar score of 7 or higher at birth
  • Stability of the baby (near discharge)
  • Having mother's milk

Exclusion Criteria:

  • Parents' reluctance to participate in the study
  • Babies younger than 35 weeks and older than 37 weeks
  • Babies receiving phototherapy
  • Finding a congenital anomaly in infants
  • Apgar score below 7 at birth
  • Being connected to a mechanical ventilator

Study details
    Preterm
    Infant
    Premature
    Diseases
    Postpartum Depression
    Mother-Infant Interaction

NCT05830955

Mustafa Kemal University

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.